Quick Answer
X4 Pharmaceuticals, Inc reported Stockholders Equity of $186.29 million for fiscal year 2025.
X4 Pharmaceuticals, Inc Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $186.29M | +741.1% |
| 2024 | $22.15M | -56.7% |
| 2023 | $51.10M | -31.0% |
| 2022 | $74.05M | +15.0% |
| 2021 | $64.41M | -11.5% |
| 2020 | $72.80M | -43.7% |
| 2019 | $129.22M | +267.6% |
| 2018 | -$77.09M | -73.1% |
| 2017 | -$44.55M | -93.2% |
| 2016 | -$23.05M | +32.8% |
| 2015 | -$34.32M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $61.62M | +3.4% | +1451.7% |
| June 30, 2025 | $3.97M | -95.8% | -82.7% |
| March 31, 2025 | $22.94M | +2114.7% | +3.6% |
| December 31, 2024 | $22.15M | -56.7% | -62.9% |
| September 30, 2024 | $59.62M | -11.8% | -36.9% |
| June 30, 2024 | $94.45M | +39.9% | +9016.9% |
| March 31, 2024 | $1.04M | -98.0% | -98.0% |
| December 31, 2023 | $51.10M | -31.0% | -24.4% |
- X4 Pharmaceuticals, Inc showed an increase of +741.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2015–2025 period, X4 Pharmaceuticals, Inc’s stockholders equity has grown by 642.8% (from -$34.32 million to $186.29 million).
- The most recent figure is from X4 Pharmaceuticals, Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: